Bengaluru firm ropes in Israel’s P-Cure to launch network of compact proton therapy centres in India
The first centre, a 660-bed quaternary campus built around integrated artificial intelligence and augmented care solutions, will come up at Sentient Health City, in Jakkur. The partners will invest ₹1,900 crore to build dedicated proton therapy infrastructure across India
Israeli medical technology company P-Cure Ltd. has partnered with Bengaluru-based healthcare infrastructure firm ARISTION Proton Center Private Limited to establish a network of compact proton therapy centers across India, investing a total of ₹1,900 crore. ARISTION Proton Center will utilize P-Cure's compact, synchrotron-based proton therapy systems in India, with the first such center set to open at Sentient Health City in Jakkur.
Proton therapy is a non-invasive radiation treatment that employs a beam of positively charged particles called protons to destroy cancer cells. This treatment method is particularly advantageous because protons travel a precise distance, releasing their energy directly at the tumor site, unlike conventional radiation which can harm healthy tissue.
Lohith G. Reddy, CMD and radiation oncologist at ARISTION Proton Center, expressed India's potential for delivering world-class medical care, emphasizing the need for advanced proton and ion precision treatment on a national scale. P-Cure CEO Michael Marash highlighted India as one of the most significant growth opportunities for proton therapy, with this agreement marking a crucial milestone for P-Cure as they introduce their technology to the country for the first time.
Written by urgent.news from The Hindu's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
